Sponsor Pipeline

Trace Neuroscience, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07674667
FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS
Recruitment opened
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07674667 FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS Amyotrophic Lateral Sclerosis Recruiting
Disease Areas
Get alerts when Trace Neuroscience, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free